ASP3026
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ASP3026, covering 2014-06-11 to 2016-06-28. Get the full timeline:
Most recent: Clinical Trial Update: Study of an Investigational Drug, ASP3026, in Patients With Advanced Malignancies (Solid Tumors and B-Cell Lymphoma) [Phase 1]